About PDX PHARMACEUTICALS INC
PDX Pharmaceuticals (DBA Raksa Therapeutics) is a biopharmaceutical company leveraging nanotechnology and cancer systems biology to develop next-generation combination immunotherapies for cancer. The company is conducting IND-enabling studies for its drug candidates ARAC-02 and AIRISE-02, funded by the National Cancer Institute (NCI).
Development of novel nanotherapeutic pipelines to enhance cancer-specific immunityNanoparticle platform (Pdx-NP TM ) for co-delivering siRNA, drugs, vaccines, and/or immunotherapiesIntratumoral and systemic nano-immunotherapy for solid tumorsDevelopment of animal models of cancer for in vivo efficacy and safety evaluationCombination therapies and precision medicine in cancer
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PDX PHARMACEUTICALS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.